The shortage has been caused by increased global demand, production disruptions and limitations in the production chain, according to the Medical Products Agency.
– It is important to point out that it is inhaled cortisone that has run out, and not the bronchodilating medicine which is an emergency medicine, says Maria Ingemansson.
She sits on the board of the Swedish Pediatric Association’s sub-förening for allergy and lung medicine and explains how the healthcare system is now trying to buy medicine with inhaled cortisone from other countries.
– The demand then increases, which the companies have not anticipated and this means that there may be a secondary shortage.